Smith Group Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-430
Closed -$35K – 354
2021
Q4
$35K Hold
430
– – ﹤0.01% 211
2021
Q3
$29K Hold
430
– – ﹤0.01% 210
2021
Q2
$29K Hold
430
– – ﹤0.01% 204
2021
Q1
$22K Buy
+430
New +$21.7K ﹤0.01% 196
2020
Q1
– Sell
-19,298
Closed -$734K – 384
2019
Q4
$734K Hold
19,298
– – 0.03% 120
2019
Q3
$427K Sell
19,298
-500
-3% -$10.7K 0.02% 158
2019
Q2
$409K Buy
19,798
+67
+0.3% +$1.54K 0.01% 165
2019
Q1
$569K Buy
19,731
+100
+0.5% +$2.47K 0.02% 159
2018
Q4
$336K Sell
19,631
-65,250
-77% -$1.58M 0.01% 211
2018
Q3
$2.42M Buy
84,881
+3,380
+4% +$112K 0.07% 123
2018
Q2
$2.74M Buy
+81,501
New +$2.53M 0.08% 108

Other funds holding THC

Smith Group Asset Management's THC Position: Q1 2022 in Review

Smith Group Asset Management sold out of Tenet Healthcare (THC) in Q1 2022, closing a stake of 430 shares — an estimated $35K sold.

Smith Group Asset Management first reported a position in THC in Q2 2018 and held it in 11 quarters. The position peaked at $2.74M in Q2 2018. 404 funds tracked by Wall St. Rank hold THC as of Q1 2022.

  • Smith Group Asset Management reported no remaining Tenet Healthcare position as of Q1 2022 after selling out during the quarter.
  • Smith Group Asset Management sold 430 Tenet Healthcare shares in Q1 2022, an estimated $35K.
  • Smith Group Asset Management first reported a position in Tenet Healthcare in Q2 2018 and held it in 11 quarters.
  • Smith Group Asset Management's Tenet Healthcare position peaked at $2.74M in Q2 2018.
  • 404 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2022.

Based on Smith Group Asset Management's 13F filing for Q1 2022, filed 5 May 2022.